24-Hour Antihypertensive Effect of Oral Cilazapril? A Placebo-Controlled Study Evaluating 1, 2.5 and 5mg Once Daily

Clinical Drug Investigation

Volumn 10, Issue 4, 1995, Pages 221-227

  Carlsen, J E ^a   Buchmann, M ^b   Hoglund C ^c   Pellinen, T ^d   Honkanen, T ^e   Soerensen, O H ^f   Leth, A ^g   Maltbaek N ^g  

^a Medicon Clinical Research   (Denmark)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c Addiction Centre Stockholm   (Sweden)

^d Lauttasaaren Lääkäriasema ^*  (Finland)

^e Hämeentien Lääkärikeskus ^*  (Finland)

^f AMAGER HOSPITAL   (Denmark)

^g Medical Department C   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CILAZAPRIL;

ADULT; ANGINA PECTORIS; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ULCER;

EID: 0028802485     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/00044011-199510040-00005     Document Type: Article

References (10)

1. The pharmacokinetics and bioavailability of Cilazapril in normal man
2. Clinical pharmacology of Cilazapril
3. Antihypertensive effects and pharmacokinetics of single and consecutive doses of Cilazapril in hypertensive patients with normal and impaired renal function
4. The 24 h blood pressure responses of hypertensives to a once-a-day Cilazapril regimen
5. Characteristics of the effects of the angiotensin converting enzyme inhibitor Cilazapril on diurnal blood pressure
6. The pharmacodynamics and dose-response relationships of the angiotensin converting enzyme inhibitor, Cilazapril, in essential hypertension
7. The effect of Cilazapril, a new angiotensin converting enzyme inhibitor, on peak and trough blood pressure measurements in hypertensive patients
8. Antihypertensive duration of action of Cilazapril in patients with mild to moderate essential hypertension
9. Antihypertensive efficacy of Cilazapril in general practice: assessment by ambulatory blood pressure monitoring
10. Antihypertensive efficacy of Cilazapril 2.5 and 5.0mg once-daily versus placebo on office blood pressure and 24-hour blood pressure profile